Dr. YuBing Luo | Computational Biology | Best Researcher Award

Dr. YuBing Luo | Computational Biology | Best Researcher Award

North China University of Technology | China

Author Profile

Scopus

🎓 Academic Background

Ph.D. in Engineering

  • Institution: North University of China
  • Program: Direct-Ph.D. Program (2nd Year)

🔬 Research Experience

Research Focus:

  • Medical image segmentation and processing
  • Deep learning for histology image analysis

🏆 Honors & Awards

Academic Scholarships:

  • 2023-2024: First-Class Academic Scholarship
  • 2022-2023: Special Academic Scholarship
  • 2021-2022: First-Class Comprehensive Scholarship
  • 2021-2022: Special Academic Scholarship

Other Awards:

  • 2022-2023: Excellent Youth League Member, School Level
  • 2021-2022: Three-Good Student, North University of China

💻 Technical Skills

Programming Languages: Python, MATLAB
Deep Learning Frameworks: TensorFlow, PyTorch
Tools: OpenCV, Scikit-Learn, Keras

🌟 Self-Evaluation

Proactive and skilled in public relations, with strong communication abilities and experience in event planning and organization. Highly responsible, hardworking, and adaptive to changes and challenges. Possesses excellent learning capabilities with a strategic approach to skill development and continuous improvement.

✨Conclusion:

  • In summary, this individual is a dedicated Ph.D. candidate at North University of China, specializing in advanced medical image segmentation and deep learning for histology analysis. With a solid record of academic scholarships and accolades, they demonstrate exceptional technical skills in Python, MATLAB, and deep learning frameworks. Their commitment to learning, strong organizational abilities, and adaptable, challenge-ready mindset make them a valuable asset in the fields of biomedical engineering and deep learning.

📊🔬NOTABLE PUBLICATION:
  • Title: Boundary Fusion Multi-Scale Enhanced Network for Gland Segmentation in Colon Histology Images
    • Authors: Luo, Y., Qin, P., Chai, R., Zhai, S., Yan, J.
    • Journal: Biomedical Signal Processing and Control
    • Year: 2024

 

  • Title: FFS-Net: Fourier-Based Segmentation of Colon Cancer Glands Using Frequency and Spatial Edge Interaction
    • Authors: Luo, Y.B., Cai, J.H., Qin, P.L., Zhai, S.J., Qin, J.
    • Journal: Expert Systems with Applications
    • Year: 2025

Dr. Jordan Leal | Stem Cell Therapy | Best Researcher Award

Dr. Jordan Leal | Stem Cell Therapy | Best Researcher Award

University of Kansas Cancer Center | United States

Author Profile

ORCID ID

🏥Professional Summary

  • Jordan Leal is a board-certified Nurse Practitioner with extensive experience in hematologic malignancies, cellular therapeutics, and blood and marrow transplantation at the University of Kansas Health System (TUKHS). Since joining TUKHS in 2009 and advancing to the role of Nurse Practitioner in 2014, Jordan has become proficient in critical procedures such as bone marrow biopsies, lumbar punctures, and the administration of intrathecal chemotherapy. In December 2023, Jordan graduated with a Doctor of Nursing Practice (DNP), further specializing in quality improvement through projects focused on early detection of steroid-induced hyperglycemia. Jordan is dedicated to advancing transplant medicine, regularly attending industry conferences, including ASTCT Tandem Meetings and regional symposia on hematologic malignancies.

👩‍⚕️Employment History

  • BMT APP Coordinator | Blood and Marrow Transplant Program, University of Kansas Cancer Center
  • 2022 – Present
  • Nurse Practitioner | Blood and Marrow Transplant Program, University of Kansas Cancer Center
  • 2014 – Present
  • Registered Nurse | Medical/Transplant Intensive Care Unit, University of Kansas Health System
  • 2009 – 2014

🎓Education

  • Doctor of Nursing Practice (DNP) | University of Kansas School of Nursing
  • Graduated: December 2023
  • Project: “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia”
  • Master of Science in Nursing (MSN) | University of Kansas School of Nursing
  • Graduated: May 2014
  • Specialization: Adult-Gerontology
  • Bachelor of Science in Nursing (BSN) | University of Kansas School of Nursing
  • Graduated: May 2009

🏆Honors and Awards

  • APP Best Abstracts, 3rd Place (2024)
  • APP of the Year Nominee (2023)
  • School of Nursing Spring 2023 Scholarship Award
  • KUMC Auxiliary Grant Recipient (2022)
  • Dean’s Award for Outstanding Service (2009)

🎤Presentations and Lectures

  • Podium Presentation: “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients,” ASTCT Tandem Meetings (2024)
  • Virtual Presentation: “Advanced Cell Therapy: BiTE/TriTE, Allogeneic CAR-T, Off-the-Shelf Products,” ASTCT Clinical Education Conference (2023)
  • Poster Presentation: “Managing Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant with Onco-Endocrinology Team,” APP Symposium, TUKHS (2022)

📄Certifications

  • Adult-Gerontology Nurse Practitioner | American Academy of Nurse Practitioners Certification Board (AANP), Expires: Dec 2024
  • Blood and Marrow Transplant Certified Nurse (BMTCN) | Oncology Nursing Certification Corporation, Expires: Dec 2025
  • ONS Chemotherapy/Biotherapy Certification | Oncology Nursing Society, Expires: Aug 2024
  • Basic Life Support | American Heart Association, Expires: Mar 2024

👥Professional Affiliations

  • American Society for Transplantation and Cellular Therapy (ASTCT) | Member since 2023

📋Professional Committees

  • APP Peer Review Committee | The University of Kansas Health System, May 2020 – Present
  • APP Professional Subcommittee | The University of Kansas Health System, February 2023 – Present
  • Continuing Education Conference (CEC) Planning Committee | American Society for Transplantation and Cellular Therapy, Summer 2022 – Present

✨Conclusion:

  • Jordan Leal, DNP, AGNP-C, BMTCN, exemplifies dedication to advancing clinical excellence in hematologic and cellular therapeutics. With over a decade of specialized experience at the University of Kansas Health System, Jordan’s expertise spans critical procedural skills, quality improvement projects, and comprehensive patient care in blood and marrow transplant. Jordan’s academic achievements, industry-recognized presentations, and active involvement in professional committees underscore a commitment to both innovative patient care and professional development. Through continued education, research, and mentorship, Jordan Leal is a driving force in improving outcomes and shaping the future of transplant nursing.

📊🔬NOTABLE PUBLICATION:

  • Title: Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients: A Quality Improvement Project
    • Authors: Jordan Leal, William Wesson, Liza Rodriguez, Jason Gray, Kelly Bosak, Joseph McGuirk, Kristin Grdinovac
      Journal: Transplantation Reports
      Year: 2024

Prof Dr. Yinyuan Ding | Tumorigenesis | Best Researcher Award

Prof Dr. Yinyuan Ding | Tumorigenesis | Best Researcher Award

Chongqing Medical University | China

Author Profile

Scopus

ORCID ID

Professor Yinyuan Ding

🌟 Professor of Oncology
🏥 Chongqing Medical University

🎓 Academic and Professional Background:

Professor Yinyuan Ding obtained a Ph.D. from Peking University in 2011 and pursued postdoctoral training at UT Southwestern Medical Center, where he was later promoted to Assistant Professor in 2018. In 2019, he returned to China and joined Chongqing Medical University as a professor. His research explores tumorigenesis and glucolipid metabolic disorders, focusing on the LRP1 receptor’s role in liver and vascular signaling, with implications for novel treatments for Hepatocellular Carcinoma (HCC) and Metabolic Associated Steatohepatitis-Liver Disease (MASLD).

🔬 Research and Innovations:

  • Principal Investigator
    2023-2026: “The role of LRP1 in hepatic glucose metabolism and HCC progression” (National Natural Science Foundation of China)
    2021: “The role of Asprosin in hepatocellular carcinoma” (Chongqing Municipal Human Resources Bureau)

 

  • Participant
    2015-2020: “VLDL and ApoE receptors metabolism” (NIH-NHLBI)
    2011-2015: “Cell signaling and cholesterol-lipoprotein receptors” (NIH)

📚 Journals Published:

Advanced Science, Elife, Science Signaling, EBioMedicine, JBC

🤝 Collaborations:

Collaborates with Joachim Herz (UT Southwestern Medical Center, USA)

👥 Professional Memberships:

Director of the China Branch, International Atherosclerosis Society

🧬 Areas of Research:

  • Oncology
  • Tumorigenesis
  • Hepatology
  • Lipoprotein & Lipid Research

📝 Contributions:

Professor Ding’s groundbreaking research on LRP1 has revealed its multifaceted roles in regulating cholesterol and glucose metabolism. His work identified a critical mechanism by which LRP1 affects hepatic insulin resistance, dyslipidemia, and HCC progression. This novel insight into LRP1’s function opens pathways for innovative therapeutic strategies for cancer and metabolic disorders.

Conclusion:

In summary, Professor Yinyuan Ding is a distinguished expert in oncology and hepatology, with a strong focus on the molecular mechanisms of tumorigenesis and lipid metabolism disorders. His innovative research on LRP1 has led to significant breakthroughs in understanding liver disease and cancer progression, paving the way for novel therapeutic strategies. With a wealth of experience from top institutions and numerous prestigious publications and patents, Professor Ding continues to make impactful contributions to the field of cancer research, driving advancements in both basic science and clinical applications. 🌟

📊🔬NOTABLE PUBLICATION:

1. LRP1 facilitates hepatic glycogenesis by improving the insulin signaling pathway in HFD-fed mice

  • Authors: Guo, X., Pu, J., Tang, Z., Liu, T., Ding, Y.
  • Journal: Animal Models and Experimental Medicine
  • Year: 2024

2. Erratum: Correction: LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis

  • Authors: Xian, X., Ding, Y., Dieckmann, M., Tsai, S., Herz, J.
  • Journal: eLife
  • Year: 2017 (Erratum published in 2024)

3. Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1-Mediated Activation of NF-κB Signaling

  • Authors: Guo, X., Yang, F., Liu, T., Herz, J., Ding, Y.
  • Journal: Advanced Science
  • Year: 2024

Dr. Salem Baldi | Cancer Diagnosis | Best Researcher Award

Dr. Salem Baldi | Cancer Diagnosis | Best Researcher Award

Shaoyang University | China

Author Profile

Scopus

ORCID ID

Google Scholar

🌍Dr. Salem Baldi, Ph.D.
Associate Professor, Medical Laboratory Diagnostics🔬:

🧬Biography:

Dr. Salem Baldi is an esteemed Associate Professor at the Department of Medical Laboratory Diagnostics, Shaoyang University, China. With a strong background in biochemistry, molecular biology, and clinical diagnostics, he has made noteworthy contributions to cancer research and genetic diagnostics 🧬. He previously worked as a Biochemistry Research Scientist at Anxuyuan Biotechnology in Shenzhen, where he applied his expertise in molecular diagnostics.

Dr. Baldi holds a Ph.D. in Clinical Laboratory Diagnostics from Dalian Medical University and a Master’s in Molecular Genetics from Jiamusi University, China. His research expertise spans cancer cell biology, DNA library preparation, and advanced genetic techniques such as CRISPR/Cas9 for disease modeling. 🧫

Fluent in English, Arabic, and Chinese, Dr. Baldi is deeply engaged in the global scientific community, holding memberships in the European Society for Blood and Marrow Transplantation and the Arab Society of Genetic Counselors. His remarkable dedication to science has earned him numerous awards, recognizing his impact in both academic and scientific circles. 🏅

Beyond his professional life, Dr. Baldi enjoys soccer, badminton, tennis, traveling, reading, and gardening ⚽🌿📚.

🧪Research Interests:

  • Cancer Diagnostics 🧫
  • Molecular Genetics 🧬
  • Clinical Laboratory Science 🧪
  • Innovative Approaches in Medical Research 🌱

📊Skills & Expertise:

  • Mammalian Cell Culture (Primary and Cancer Cells)
  • Molecular Cloning, Transfection, Gene Expression
  • PCR, qPCR, Real-Time PCR 🔬
  • Western Blotting, SDS-PAGE, Immunofluorescence
  • DNA Library Preparation (NGS, Illumina, PacBio) 📊
  • CRISPR/Cas9 Disease Modeling 🧬

🏅Awards & Recognitions:

  • 2021: Excellence in Scientific Research 🏅, Yemeni Ministry of Higher Education
  • 2022: Certificate of Gratitude 🙏, Yemeni Students Union, China

🌍Languages:

  • English
  • Arabic
  • Chinese

Conclusion:

🌱Dr. Salem Baldi is a dedicated researcher and educator, committed to advancing the field of medical laboratory diagnostics. His expertise in molecular biology and biochemistry, coupled with a global perspective and fluency in multiple languages, positions him as a leader in cancer research and diagnostics. His passion for integrating traditional and modern medical practices drives his innovative approach to improving patient outcomes. Beyond the lab, his diverse interests reflect a well-rounded individual who is deeply engaged in both his personal and professional pursuits. ✨

📊🔬NOTABLE PUBLICATION:

  • Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
    Authors: Alradhi, M., Safi, M., Tao, S., Baldi, S., Li, X.
    Journal: Therapeutic Advances in Urology
    Year: 2022

 

  • Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study
    Authors: Al-Danakh, A., Safi, M., Alradhi, M., Zhu, X., Yang, D.
    Journal: Cells
    Year: 2022

 

  • ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression
    Authors: Baldi, S., Zhang, Q., Zhang, Z., Al-Nusaif, M., Zuo, Y.
    Journal: Journal of Cellular and Molecular Medicine
    Year: 2022

 

  • Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data
    Authors: Baldi, S., He, Y., Ivanov, I., Gao, Y., Tian, H.
    Journal: Frontiers in Molecular Biosciences
    Year: 2022

 

  • Unraveling the salt tolerance of Phi29 DNA polymerase using compartmentalized self-replication and microfluidics platform
    Authors: Sun, Y., Ko, D.H., Gao, J., He, Y., Tian, H.
    Journal: Frontiers in Microbiology
    Year: 2023

Dr. Alaa Darkazally | Gastric Cancer | Best Researcher Award

Dr. Alaa Darkazally | Gastric Cancer | Best Researcher Award

Damascus University | Syria

Author Profile

ORCID Id

📊Dr. Alaa Darkazally

📍 Pharmacist | Academic Supervisor | Researcher
🌍 Damascus, Syria

📍Summary

Dr. Alaa Darkazally is a dedicated pharmacist and academic supervisor with extensive experience across pharmaceutical industries, academia, and humanitarian sectors. With a strong academic background, including a Master’s in Pharmacology from Damascus University and ongoing studies towards a Master’s in Medical Education at the Syrian Virtual University, Dr. Darkazally combines academic expertise with practical experience in pharmacy and healthcare.

🌍Professional Experience

💼Volunteer Work

  • Volunteer at Saiyar Project (September 2022 – Present)
    • Contributing to voluntary actions in various community initiatives.

    Volunteer at Samma3t Hakeem (February 2022 – Present)

    • Applying pharmaceutical expertise in humanitarian work.

    Volunteer at A+ Pharmacists Team (July 2022 – January 2023)

    • Gaining experience in scientific research and promoting knowledge exchange.

🌐Education

  • Master in Medical Education (in progress), Syrian Virtual University (2026 expected)
  • Master’s in Pharmacology, Damascus University (2023)
  • Bachelor’s Degree in Pharmacy and Pharmaceutical Industries, Damascus University (2017)

🎯Skills

  • 💼 Microsoft Word, PowerPoint, Excel
  • 🎯 Leadership, Critical Thinking, Problem-Solving, Communication Skills
  • 🌐 Arabic (Native), English (Excellent), French (Beginner)

Conclusion

With a strong commitment to education and community service, this professional continuously seeks opportunities to grow and contribute positively to their organization. Their extensive background in pharmacy and education, combined with their dedication to humanitarian efforts, positions them as a valuable asset in any healthcare or academic setting. 🌟

📊🔬NOTABLE PUBLICATION:

    • “Troxerutin effect on gastric ulcers induced by ketorolac in rats: Relation with oxidative stress”:
      • Authors: Alaa Zouher Darkazally, Amirah Alnour, Shadi Homsi
      • Journal: Heliyon
      • Year: 2024

Dr Shengwei Li | Computer-Assisted Surgical Planning | Best Researcher Award

Dr Shengwei Li | Computer-Assisted Surgical Planning | Best Researcher Award

Peking Union Medical College | China

AUTHOR PROFILE

Scopus

🎓EARLY ACADEMIC PURSUITS 

Shengwei Li graduated from the prestigious Top Pilot Class at Southeast University in 2021. He then embarked on a promising academic career as a doctoral student at Peking Union Medical College, starting in 2022. His foundational studies laid a strong groundwork for his future contributions in the field of interventional oncology. Shengwei has gained valuable experience, particularly in the clinical setting of Zhongda Hospital, where he worked for three years.

🏥PROFESSIONAL ENDEAVORS 

Shengwei’s professional experience specializes in the field of interventional oncology, with a focus on treating malignant tumors. His expertise shines in managing complex cases such as unresectable hepatocellular carcinoma and early-stage lung cancer. His clinical acumen is further enriched through his active participation in several clinical trials, including multi-center randomized controlled trials, all of which contribute to cutting-edge oncology treatments.

🧑‍🔬CONTRIBUTIONS AND RESEARCH FOCUS ON COMPUTER-ASSISTED SURGICAL PLANNING

Shengwei’s research efforts are centered on computer-assisted surgical planning, a field where he has made significant advancements. His major contributions include the development of deep learning-based algorithms that assist in dose calculation for 125I seed-loaded stents and automated image segmentation for liver and vascular systems. These innovations directly improve preoperative planning and surgical outcomes for hepatocellular carcinoma (HCC). Additionally, he has introduced an automatic planning system for CT-guided percutaneous liver tumor ablation, which promises to make treatment planning more efficient for healthcare professionals.

🔬IMPACT AND INFLUENCE 

His published works—five research articles in indexed journals—are primarily focused on improving treatments for unresectable HCC. Shengwei’s groundbreaking research on deep learning and medical algorithms is expected to significantly impact the field of interventional oncology, particularly for hard-to-treat liver cancers. His innovations aim to increase the accuracy and effectiveness of tumor ablation procedures, ultimately benefiting patients and advancing the field of oncology.

📚ACADEMIC CITES AND CREDENTIALS 

Shengwei’s research has garnered recognition within the academic community, reflected by his citation index of 2 and the growing influence of his published works. He has completed 3 research projects and holds 3 patents under process, marking his commitment to innovation. His work has been published in 5 indexed journals, and his ongoing efforts ensure that he continues contributing to the field of medical research and technology.

🔮LEGACY AND FUTURE CONTRIBUTIONS 

Looking ahead, Shengwei Li’s work promises to bridge the gap between clinical practice and technological innovation. His vision of integrating advanced computational techniques with interventional oncology has the potential to transform the way complex cancers are treated. His ongoing research will likely continue to influence future medical practices and technologies, making him a promising figure in both medicine and engineering.

CONCLUSION

Shengwei Li is a promising and dedicated researcher whose work in interventional oncology and computer-assisted surgical planning is making significant strides in the treatment of complex cancers like unresectable hepatocellular carcinoma. His innovative approach, combining deep learning algorithms with clinical practice, highlights his potential to revolutionize cancer treatments. With multiple patents in progress and several impactful research publications, he is well-positioned to contribute further to the advancement of medical science. Shengwei’s interdisciplinary expertise and dedication make him a deserving candidate for the Best Researcher Award.

📊🔬NOTABLE PUBLICATION:

    • Automated segmentation of liver and hepatic vessels on portal venous phase computed tomography images using a deep learning algorithm
      • Authors: Li, S., Li, X.-G., Zhou, F., Peng, J., Li, B.
      • Journal: Journal of Applied Clinical Medical Physics
      • Year: 2024

     

    • Acute-phase plasma proteomics of rabbit lung VX2 tumors treated by image-guided microwave ablation
      • Authors: Cheng, L., Peng, J.-Z., Li, S.-W., Bie, Z.-X., Li, X.-G.
      • Journal: Frontiers in Oncology
      • Year: 2024

Prof. Qingyong Chen | Head Tumors | Best Researcher Award

Prof. Qingyong Chen | Head Tumors | Best Researcher Award

Binzhou Medical University | China

AUTHOR PROFILE

Scopus

🎓EARLY ACADEMIC PURSUITS 

Chen Qingyong, M.S., began his academic journey with a strong foundation in clinical medicine, receiving his education from The Second School of Clinical Medicine at Binzhou Medical University. His early academic focus was centered around basic medical sciences, laying the groundwork for his expertise in bioinformatics, statistical methods, and biomedical research. His passion for learning and dedication to mastering complex subjects drove him to excel in the medical field, and he quickly became proficient in handling both theoretical and practical aspects of medical research.

👨‍⚕️PROFESSIONAL ENDEAVORS 

As a Resident Physician at Binzhou Medical University, Chen Qingyong is immersed in both clinical practice and research. His responsibilities extend beyond patient care to encompass cutting-edge scientific investigations. He demonstrates an impressive ability to combine clinical knowledge with advanced computational tools, excelling in areas such as imaging genomics, machine learning, and deep learning for predictive modeling. Chen’s dual focus on clinical practice and medical research makes him a well-rounded medical professional with a unique skill set in modern healthcare technologies.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON HEAD TUMORS

Over the past year, Chen Qingyong has published 12 first-author papers, showcasing his proficiency in various advanced research methods, including Mendelian Randomization, Meta-Analysis, and basic experimental techniques. His research is particularly focused on leveraging bioinformatics to analyze complex medical data, contributing to the fields of imaging genomics and machine learning-based predictive models. Chen’s ability to utilize tools like R and Python has enabled him to derive meaningful insights from large datasets, advancing the understanding of disease mechanisms and aiding in the development of predictive diagnostics.

📊IMPACT AND INFLUENCE 

Chen’s research is gaining recognition for its contributions to the intersection of clinical medicine and computational sciences. His work on deep learning algorithms and bioinformatics for predictive diagnostics is helping to shape the future of personalized medicine. His studies offer new avenues for improving patient outcomes through the integration of machine learning into clinical decision-making processes. Moreover, his proficiency in Meta-analysis and Mendelian randomization has added depth to the interpretation of epidemiological data, offering more robust conclusions on disease causality.

📚ACADEMIC CITATIONS AND RECOGNITION 

Chen Qingyong’s research has been cited in several high-impact journals, reflecting the significance of his contributions to medical science. His ability to publish consistently and effectively within a short period demonstrates not only his dedication but also the growing interest and reliance on his work by the academic community. These citations solidify his position as an emerging researcher whose work holds importance for both current medical challenges and future innovations in healthcare.

🌟LEGACY AND FUTURE CONTRIBUTIONS 

Chen Qingyong’s future appears promising as he continues to bridge the gap between medicine and technology. His focus on integrating deep learning and imaging genomics with clinical applications suggests that he will remain at the forefront of medical research innovations. His contributions are expected to have a lasting impact, particularly in the areas of personalized medicine, predictive diagnostics, and epidemiological research. As a young researcher with significant accomplishments already under his belt, Chen is poised to leave a profound legacy in both clinical practice and biomedical research.

CONCLUSION 

Chen Qingyong is a rising star in the medical field, known for his extensive research in bioinformatics, machine learning, and genomics. His early accomplishments suggest a future of impactful discoveries and innovations that will shape the direction of modern healthcare. By merging clinical expertise with cutting-edge computational methods, Chen is paving the way for advancements in predictive medicine, ultimately improving patient care and outcomes.

📊🔬NOTABLE PUBLICATION:

    • Predicting Biomarkers in Laryngeal Squamous Cell Carcinoma Based on the Cytokine-Cytokine Receptor Interaction Pathway
      • Authors: Chen, Q., Wang, D., Chen, Z., Li, P., Lv, H.
      • Journal: Heliyon
      • Year: 2024

     

    • Application of Retroauricular Sulcus Incision in the Operation of Benign Tumors in the Deep Lobe of Parotid Gland
      • Authors: Chen, Q., Sun, D., Wang, D., Yang, Y., Lyu, H.
      • Journal: Chinese Journal of Otorhinolaryngology Head and Neck Surgery
      • Year: 2023

Prof. Huaiqing Lv | Neck Tumors | Best Researcher Award

Prof. Huaiqing Lv | Neck Tumors | Best Researcher Award

Shandong Second Medical University | China

Author Profile

Scopus

🌟 Dr. Lv Huaiqing, M.D.

Chief Physician & Master’s Degree Supervisor

Director of Otorhinolaryngology & Head and Neck Surgery

Linyi People’s Hospital, Shandong Province

👩‍⚕️ Professional Summary:

Dr. Lv Huaiqing is a distinguished Chief Physician and subject leader at Linyi People’s Hospital, specializing in Otorhinolaryngology and Head and Neck Surgery. With extensive experience in clinical practice and research, Dr. Lv has significantly contributed to the field through her leadership roles and numerous scientific projects.

**🌐 Part-Time Roles:

  • Vice Chairman, Otorhinolaryngology, Head and Neck Surgery Committee, Shandong Provincial Medical Association
  • Vice Chairman, Hearing and Balance Medical Association, Shandong Provincial Medical Association
  • Member, Voice Committee, Otorhinolaryngology Committee, Chinese Association of Integrative Medicine
  • Standing Member, Head and Neck Tumor Committee, China Medical Education Association
  • Vice Chairman, Ear, Nose and Throat Committee, Shandong Association of Integrative Medicine
  • Vice Chairman, Pharyngeal, Head and Neck Surgery Committee, Shandong Provincial Association of Health Management
  • Director, Linyi Otorhinolaryngology Quality Control Center
  • Linyi Health Leader
  • Director, Otolaryngology Branch, Linyi Physicians Association

📚 Research Contributions:

Dr. Lv has authored 13 papers as the first author or corresponding author in the past year. She has presided over 3 provincial and municipal level projects, including:

  • Application of Posterior Auricular Groove Incision in Surgery of Benign Tumor of Parotid Gland
  • Evaluation of Orbital Invasion of Sinus Tumor Based on CT, MRI, and Machine Learning Models
  • Posterior Auricular Groove Incision in Surgery of Benign Tumor of Superficial Parotid Gland

Her research has received significant funding of 400,000 RMB and has led to several municipal science and technology awards. The research team excels in various methods, including bioinformatics, meta-analysis, and machine learning predictive models.

🎓 Teaching Commitment:

Currently, Dr. Lv supervises Master’s degree students at Qingdao University, Shandong Second Medical University, and Binzhou Medical College, having guided 10 students to date.

🔬 Current Publications:

She is also the first author or corresponding author of approximately 20 newly accepted and submitted articles in Chinese core or SCI journals.

Dr. Lv Huaiqing’s dedication to otorhinolaryngology, combined with her commitment to research and education, makes her a leading figure in her field.

🔔 Conclusion

Dr. Lv Huaiqing stands out as a prominent leader in Otorhinolaryngology and Head and Neck Surgery, with a rich background in clinical practice, research, and education. Her extensive involvement in various medical associations and committees demonstrates her commitment to advancing the field and enhancing patient care. Through her innovative research projects and dedication to mentoring future healthcare professionals, Dr. Lv continues to make significant contributions to medical science and the development of her specialty in Shandong Province and beyond.

📊🔬NOTABLE PUBLICATION:

    • Circ_0058124 upregulates MAPK1 expression to promote proliferation, metastasis and metabolic abilities in thyroid cancer through sponging miR-940
      • Authors: Sun, D., Chen, L., Lv, H., Liu, X., Zhang, X.
      • Journal: OncoTargets and Therapy
      • Year: 2020

     

    • Predicting biomarkers in laryngeal squamous cell carcinoma based on the cytokine-cytokine receptor interaction pathway
      • Authors: Chen, Q., Wang, D., Chen, Z., Li, P., Lv, H.
      • Journal: Heliyon
      • Year: 2024

     

    • Genetically predicted allergic rhinitis causally increases the risk of erectile dysfunction
      • Authors: Li, P., Meng, Z., Lin, L., Chen, Z., Lv, H.
      • Journal: Frontiers in Genetics
      • Year: 2024

     

    • A novel frameshift mutation of the endoglin (ENG) gene causes hereditary hemorrhagic telangiectasia in a Chinese family
      • Authors: Li, P., Gao, C., Wei, Y., Shao, Q., Lv, H.
      • Journal: European Archives of Oto-Rhino-Laryngology
      • Year: 2024

     

    • Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway
      • Authors: Chen, L., Sun, D.-Z., Fu, Y.-G., Gao, Y., Zhang, X.-Y.
      • Journal: Cellular Signalling
      • Year: 2020

Prof. Hongsheng Liu | Pharmaco-Oncology | Best Researcher Award

Prof. Hongsheng Liu | Pharmaco-Oncology | Best Researcher Award

Liaoning University | China

Author Profile

Scopus

🌟 Professor Hongsheng Liu: A Pioneer in Microbiology and Bioinformatics

Professor, School of Pharmaceutical Sciences, Liaoning University, China

🔬 Academic and Professional Background

Professor Hongsheng Liu obtained a Master’s degree in Microbiology from China Agricultural University in 1991 and later pursued a Ph.D. in Microbiology and Bioinformatics at Gifu University School of Medicine, Japan, in 2004. Over the years, he has expanded his expertise by serving as a visiting scholar at prestigious institutions such as Wuhan University, the University of Hong Kong, Harvard Medical School, and Hebrew University of Jerusalem. His career reflects a deep commitment to advancing the fields of microbiology, bioinformatics, and pharmaceutical sciences.

💡 Research and Innovations

Professor Liu has completed an impressive 74 research projects and authored over 100 journal articles (SCI, Scopus, etc.), accumulating a citation index of 2721. His work spans diverse areas, including the discovery of the novel microorganism Paenibacillus liaoningensis sp. nov. and the investigation of influenza virus interactions. His contributions to computational biology include the development of several predictive algorithms and online platforms like CarcinoPred-EL and LiverToxPred-EL. Additionally, Professor Liu holds 37 patents, has published 4 books, and has led 7 industry consultancy projects.

📚 Published Works and Collaborations

Professor Liu’s collaborative research includes partnerships with renowned institutions such as the University of Toledo, Harvard Medical School, and Eberhard Karl University of Tübingen. He has also served as a guest editor for Frontiers in Microbiology (2017-2018). His dedication to both basic and applied research continues to push the boundaries of pharmaceutical sciences.

👥 Professional Memberships

He is an active member of the Chinese Society for Microbiology (CSM) and the Chinese Chemical Society (CCS).

🌍 Areas of Research

Professor Liu specializes in computer-aided drug design and the simulation of biomacromolecule interactions, with a focus on studying lncRNAs and disease relationships, and designing stable recombinant proteins using engineered bacteria.

🔔 Conclusion

Professor Hongsheng Liu stands as a distinguished leader in microbiology and bioinformatics, contributing significantly to drug design, biomolecular simulation, and microbial discovery. His broad academic collaborations, cutting-edge innovations, and vast research output underscore his influence in the scientific community. Through his extensive work on predictive algorithms, microbial databases, and recombinant protein design, he has made impactful advancements in pharmaceutical sciences. With over 100 journal publications, 37 patents, and numerous prestigious collaborations, Professor Liu’s dedication to advancing scientific knowledge and improving human health is truly commendable.

📊🔬NOTABLE PUBLICATION:

    • Article Title: Ensemble multiclassification model for aquatic toxicity of organic compounds
      Authors: Li, X., Liu, G., Wang, Z., Liu, H., Ai, H.
      Journal: Aquatic Toxicology
      Year: 2023

     

    • Article Title: Construction of an oxidative stress-related lncRNAs signature to predict prognosis and the immune response in gastric cancer
      Authors: Zhang, H., Feng, H., Yu, T., Ma, L., Liu, H.
      Journal: Scientific Reports
      Year: 2023

     

    • Article Title: CBIL-VHPLI: a model for predicting viral-host protein-lncRNA interactions based on machine learning and transfer learning
      Authors: Zhang, M., Zhang, L., Liu, T., Zhao, J., Liu, H.
      Journal: Scientific Reports
      Year: 2024

     

    • Article Title: Construction of highly active and stable recombinant nattokinase by engineered bacteria and computational design
      Authors: Wang, L., Meng, J., Yu, X., Zhang, L., Liu, H.
      Journal: Archives of Biochemistry and Biophysics
      Year: 2024

     

    • Article Title: Effects of dietary supplementation of gallic tannic acid on growth, intestinal digestive enzymes activity, innate immunity, morphology, and microbial composition of Cyprinus carpio
      Authors: Feng, H., Zhao, S., Ma, X., Liu, Z., Liu, H.
      Journal: Aquaculture International
      Year: 2024

Prof. Xiaodi Niu | Biosensor | Best Researcher Award

Prof. Xiaodi Niu | Biosensor | Best Researcher Award

Jilin University | China

AUTHOR PROFILE

Scopus

🧑‍🎓 NIU XIAODI – PROFESSOR, FACULTY OF VETERINARY MEDICINE, JILIN UNIVERSITY

🎓 EDUCATION BACKGROUND

  • 2005-09 to 2008-06: PhD in Natural Medicinal Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences
  • 2002-09 to 2005-07: Master’s in Physical Chemistry, Northeast Normal University
  • 1998-09 to 2002-07: Bachelor’s in Chemistry Education, Northeast Normal University

🧑‍🔬 POSTDOCTORAL WORK EXPERIENCE

  • 2014-06 to 2016-06: Postdoctoral Research, College of Veterinary Medicine, Jilin University

👩‍🏫 SCIENTIFIC RESEARCH AND ACADEMIC WORK EXPERIENCE

  • 2018-01 to Present: Professor, College of Veterinary Medicine, Jilin University
  • 2010-09 to 2017-12: Associate Professor, College of Veterinary Medicine, Jilin University
  • 2008-07 to 2010-08: Lecturer, College of Veterinary Medicine, Jilin University

🧪 EARLY ACADEMIC PURSUITS

Niu Xiaodi’s academic journey began with a Bachelor’s in Chemistry Education, followed by a Master’s in Physical Chemistry from Northeast Normal University. She further honed her expertise by obtaining a PhD in Natural Medicinal Chemistry at the prestigious Changchun Institute of Applied Chemistry. These formative years laid a strong foundation for her subsequent academic and research endeavors, focusing on the interface of chemistry and veterinary medicine.

🏅 PROFESSIONAL ENDEAVORS

Throughout her career at Jilin University, Niu Xiaodi has progressed through various academic ranks, from Lecturer to Associate Professor, and currently serves as a full Professor in the College of Veterinary Medicine. Her postdoctoral work at the same institution further enriched her knowledge and research skills, particularly in veterinary pharmacology and molecular mechanisms of medicinal compounds.

🔬 RESEARCH FOCUS

Niu’s research primarily revolves around natural medicinal chemistry and veterinary pharmacology, with a specific emphasis on the molecular mechanisms of bioactive compounds. Her notable research contributions include investigating the inhibition of bacterial enzymes and exploring anti-aging compounds targeting specific cellular proteins.

National Natural Science Foundation Projects

  1. Cyanidin Inhibits Staphylococcus aureus Serine/Threonine Protein Phosphatase (Stp1)
    • Project ID: 32072919
    • Duration: 2021-01-01 to 2024-12-31
    • Funding: RMB 580,000
    • Role: Principal Investigator
    • Focus: This project investigates the molecular mechanism of cyanidin’s inhibition of Stp1 in Staphylococcus aureus and analyzes its structure-activity relationship, which may lead to the development of new antibacterial agents.

 

  1. Theaflavins Inhibition of Class B β-Lactamase
    • Project ID: 31872525
    • Duration: 2019-01-01 to 2022-12-31
    • Funding: RMB 600,000
    • Role: Host
    • Focus: This research focuses on the structural analysis of theaflavins, a type of polyphenol, in their ability to inhibit Class B β-lactamase enzymes, which are responsible for antibiotic resistance.

Other Research Projects

  1. Anti-Aging Activity of Ursolic Acid Targeting AMP-Activated Protein Kinase (AMPK)
    • Funding Source: Jilin Provincial Department of Science and Technology
    • Project ID: 20190701032GH
    • Duration: 2019-01 to 2021-12
    • Funding: RMB 150,000
    • Role: Principal Investigator
    • Focus: This project examined how ursolic acid, a natural compound, activates AMPK to combat aging, highlighting potential therapeutic applications for age-related diseases.

🌍 IMPACT AND INFLUENCE

Niu Xiaodi’s work has made significant contributions to both the fields of veterinary medicine and natural product chemistry. Her research on inhibiting bacterial enzymes addresses the growing issue of antibiotic resistance, a global health crisis. Additionally, her exploration of natural compounds with anti-aging properties has implications for longevity research and the development of therapeutic interventions for age-related diseases.

📚 ACADEMIC CITATIONS AND LEGACY

Niu Xiaodi’s publications are widely cited in the fields of medicinal chemistry and veterinary pharmacology, reflecting the relevance and impact of her work. Her insights into the structure-activity relationships of bioactive compounds are particularly influential in guiding future drug development. With a robust track record of research projects, including National Natural Science Foundation projects, her contributions continue to shape academic discourse and practical applications in the medical and veterinary fields.

🚀 FUTURE CONTRIBUTIONS

Looking ahead, Niu Xiaodi aims to expand her research into novel therapeutic strategies targeting antibiotic resistance and cellular aging. Her future work will likely delve deeper into the mechanisms of bioactive compounds, unlocking new potential in both veterinary medicine and human health.

Through her extensive academic journey, pioneering research, and impactful contributions, Niu Xiaodi has established herself as a key figure in medicinal chemistry and veterinary science. Her ongoing work promises to leave a lasting legacy in these interdisciplinary fields.

🚀 CONCLUSION

Niu Xiaodi’s impressive academic and professional journey reflects her dedication to advancing the fields of veterinary medicine and medicinal chemistry. With a solid educational foundation and extensive research experience, she has made significant contributions to understanding the biochemical mechanisms of natural compounds in combating bacterial resistance and promoting health. Her leadership in key projects has not only yielded valuable insights but also addressed pressing challenges in antibiotic resistance and aging.

📊🔬NOTABLE PUBLICATION:

    • Engineering the electronic structure of isolated manganese sites to improve the oxygen reduction, Zn-air battery and fuel cell performances
      • Authors: Bai, X., Wang, Y., Han, J., Niu, X., Guan, J.
      • Journal: Applied Catalysis B: Environmental
      • Year: 2023

     

    • Diatomic Fe-Co catalysts synergistically catalyze oxygen evolution reaction
      • Authors: Tang, T., Han, J., Wang, Z., Niu, X., Guan, J.
      • Journal: Nano Research
      • Year: 2024
    • Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria
      • Authors: Guo, Y., Liu, H., Yang, M., Feng, H., Qiu, J., Niu, X.
      • Journal: British Journal of Pharmacology
      • Year: 2024

     

    • Dibenzylideneacetone Overcomes Botrytis cinerea Infection in Cherry Tomatoes by Inhibiting Chitinase Activity
      • Authors: Niu, X., Wang, Z., Wang, C., Wang, H.
      • Journal: Journal of Agricultural and Food Chemistry
      • Year: 2023

     

    • Exploring Novel Umami Peptides from Bovine Bone Soups Using Nano-HPLC-MS/MS and Molecular Docking
      • Authors: Yang, Z., Li, W., Yang, R., Li, G., Zhao, C.
      • Journal: Foods
      • Year: 2024